Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on April 26, 2006
Journal of the American Society of Nephrology
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2004090800
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
ASN.2004090800v1
17/6/1604    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Omori, S.
Right arrow Articles by Awazu, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Omori, S.
Right arrow Articles by Awazu, M.
Related Collections
Right arrowRelated Article

Received September 28, 2004
Accepted on March 14, 2006

BASIC SCIENCE: Pathophysiology of Renal Disease and Progression

Extracellular Signal-Regulated Kinase Inhibition Slows Disease Progression in Mice with Polycystic Kidney Disease

Sayu Omori *, Mariko Hida *, Hisayo Fujita *, Hisahide Takahashi {dagger}, Susumu Tanimura {ddagger}, Michiaki Kohno {ddagger}, and Midori Awazu *1

*Department of Pediatrics, Keio University School of Medicine, Tokyo, {dagger}Education and Research Center of Animal Models for Humans Diseases, Fujita Health University, Toyoake, and {ddagger}Department of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan


1 To whom correspondence should be addressed. E-mail: awazu{at}sc.itc.keio.ac.jp.


   Abstract

The expression of mitogen-activated protein kinases (MAPK) in DBA/2-pcy/pcy (pcy) mice, a murine model of polycystic kidney disease was investigated. Proliferating cell nuclear antigen-positive cells were recognized in cyst epithelium from embryonic day 14.5 to 25 wk of age. Extracellular signal-regulated kinase (ERK) was expressed in the renal tubules of control and pcy mice, but stronger immunostaining was observed in cyst epithelium. Phosphorylated ERK was detected only in pcy mice and was localized predominantly in the cysts. p38 MAPK (p38) was no longer expressed after birth in controls but was detected in the cyst epithelium and in occasional tubular cells of pcy mice at all stages examined. c-Jun N-terminal kinase (JNK) was expressed in all tubular segments of controls after neonatal day 7, whereas in pcy kidneys, tubules became positive for JNK after 8 wk, and the cysts expressed little JNK. Administration of an oral MAP/ERK kinase inhibitor, PD184352, 400 mg/kg per d, to 10-wk-old pcy mice daily for the first week and then every third day for 6 additional weeks significantly decreased BP, kidney weight, serum creatinine level, and water intake and significantly increased urine osmolality. The cystic index and expression of phosphorylated ERK and ERK were significantly lower in PD184352-treated pcy mice. These results demonstrate that the expression of MAPK is dysregulated in cyst epithelium and that inhibition of ERK slowed the progression of renal disease in pcy mice.


Related Article

MEK Inhibition Holds Promise for Polycystic Kidney Disease
James P. Calvet
J. Am. Soc. Nephrol. 2006 17: 1498-1500. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Wang, J. Jiang, Q. Guan, H. Wang, C. Y. C. Nguan, A. M. Jevnikar, and C. Du
Reduction of chronic allograft nephropathy by inhibition of extracellular signal-regulated kinase 1 and 2 signaling
Am J Physiol Renal Physiol, September 1, 2008; 295(3): F672 - F679.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
J. P. Calvet
Strategies to Inhibit Cyst Formation in ADPKD
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1205 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Shibazaki, Z. Yu, S. Nishio, X. Tian, R. B. Thomson, M. Mitobe, A. Louvi, H. Velazquez, S. Ishibe, L. G. Cantley, et al.
Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1
Hum. Mol. Genet., June 1, 2008; 17(11): 1505 - 1516.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Du, M. Ding, S. Sours-Brothers, S. Graham, and R. Ma
Mediation of angiotensin II-induced Ca2+ signaling by polycystin 2 in glomerular mesangial cells
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F909 - F918.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
O. Ibraghimov-Beskrovnaya
Molecular pathogenesis of ADPKD and development of targeted therapeutic options
Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3367 - 3370.
[Full Text] [PDF]


Home page
JGPHome page
R. A. Falin and C. U. Cotton
Acute Downregulation of ENaC by EGF Involves the PY Motif and Putative ERK Phosphorylation Site
J. Gen. Physiol., August 27, 2007; 130(3): 313 - 328.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
V. E. Torres
Water for ADPKD? Probably, Yes
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2089 - 2091.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. P. Calvet
MEK Inhibition Holds Promise for Polycystic Kidney Disease
J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1498 - 1500.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP